AIKI Market Cap History
Below is a table of the AIKI market cap history going back to 1/30/2020:

Date AIKI Market Cap

Also see: AIKI Shares Outstanding History
and AIKI YTD Return
AIKI Historical Market Cap:
+71.42% CAGR
AIKI Historical Market Cap: +71.42% CAGR

Mouse over chart for data details
1/30/2020 ...11/9/2022
Spherix is a biotechnology company seeking to develop small-molecule anti-cancer therapeutics. Co. owns the rights to patented technology from universities and researchers and it is in the process of developing therapeutic drugs through partnerships with educational institutions. Co.'s pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Co.'s AML and ALL compounds are targeted therapeutics designed to overcome various resistance mechanisms observed with the existing standard of care. DHA-dFdC, Co.'s pancreatic drug, is a compound poised to become the chemotherapy treatment for pancreatic cancer. We show 12 historical shares outstanding datapoints in our AIKI shares outstanding history coverage, used to compute AIKI market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AIKI market cap history over the course of time is important for investors interested in comparing AIKI's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AIKI versus a peer is one thing; comparing AIKI market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AIKI can fluctuate over the course of history. With this page we aim to empower investors researching AIKI by allowing them to research the AIKI market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AIKI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AIkido Pharma (AIKI) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AIMT Market Cap History
AIPT Market Cap History
AIQ Market Cap History
AITB Market Cap History
AKAO Market Cap History
AKBA Market Cap History
AKCA Market Cap History
AKER Market Cap History
AKRO Market Cap History
AKRX Market Cap History
More Healthcare companies »


AIKI Market Cap History | | Copyright © 2017 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.